Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

RecruitingOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

October 1, 2026

Study Completion Date

December 1, 2026

Conditions
Myotonic Dystrophy 1DM1
Trial Locations (17)

14642

RECRUITING

University of Rochester, Rochester

23298

RECRUITING

Virginia Commonwealth University, Richmond

32611

RECRUITING

University of Florida, Gainesville

43210

RECRUITING

Ohio State University, Columbus

52242

RECRUITING

University of Iowa, Iowa City

66160

RECRUITING

Kansas University Medical Center, Kansas City

77030

RECRUITING

Houston Methodist Neurological Institute, Houston

80204

RECRUITING

University of Colorado - Denver, Denver

90095

RECRUITING

University of California, Los Angeles, Los Angeles

92703

RECRUITING

University of California, San Diego, La Jolla

Unknown

ACTIVE_NOT_RECRUITING

Université de Sherbrooke, Québec

RECRUITING

Friedrich Baur Institute, Ludwig-Maximilians-Universität München, München

COMPLETED

Centro Clinico NeMO, Milan

RECRUITING

Radboud University Medical Center, Nijmegen

RECRUITING

University of Auckland, Auckland

RECRUITING

St. George's, University of London, London

RECRUITING

University College London, London

All Listed Sponsors
collaborator

University of Rochester

OTHER

collaborator

Stanford University

OTHER

collaborator

Ohio State University

OTHER

collaborator

University of Florida

OTHER

collaborator

University of Iowa

OTHER

collaborator

Ludwig-Maximilians - University of Munich

OTHER

collaborator

Fondazione Serena Onlus - Centro Clinico NeMO Milano

OTHER

collaborator

The Methodist Hospital Research Institute

OTHER

collaborator

Radboud University Medical Center

OTHER

collaborator

University College London Hospitals

OTHER

collaborator

University of California, Los Angeles

OTHER

lead

Virginia Commonwealth University

OTHER